Earnings Call · Q4 FY2022·2023-02-02

Q4 22EPS +3.23%·Rev n/aQ3 22EPS +20.83%·Rev n/aQ2 22EPS +8.33%·Rev n/aQ1 22EPS +4.76%·Rev n/a⚠ consensus missing

IRADIMED CORP IRMD

Roger Susi — Chief Executive Officer

Jack Glenn — Chief Financial Officer

−0.3%1d on move date+0.5% vs SPY3d+6.2%5d+8.9%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IRMD calls or request research access.

More IRMD calls Browse calls Request research access